GlaxoSmithKline

3327 articles about GlaxoSmithKline

• GlaxoSmithKline Files Its New Pre-Pandemic Influenza Vaccine In Europe

  1/29/2007

• GlaxoSmithKline Standardizes On Autonomy

  1/22/2007

• The Day In Review: Gemzar From Eli Lilly and Company Effective For Pancreatic Cancer

  1/18/2007

• Biovail Corporation And GlaxoSmithKline Release: Wellbutrin XR(R) Receives First European Approval

  1/16/2007

• GlaxoSmithKline Commences Tender Offer To Acquire Praecis Pharmaceuticals Incorporated

  1/9/2007

• Peptech Limited Announces Acquisition By GlaxoSmithKline Of Domantis Limited Completed

  1/8/2007

• The Day In Review: Threshold Pharmaceuticals, Inc. Reports Success Against Pancreatic Cancer

  12/28/2006

• Hospira, Inc. Launches Ondansetron Injection

  12/27/2006

• GlaxoSmithKline Receives Approvable Letter For Topical Antibiotic, Altabax(TM) (retapamulin ointment), 1%

  12/26/2006

• Bedford Laboratories To Begin Shipping Ondansetron Injection USP

  12/26/2006

• The Day In Review: Eli Lilly and Company Stops Brain Cancer Trial

  12/22/2006

• Spectrum Pharmaceuticals, Inc. Announces That Sumatriptan Injection Litigation With GlaxoSmithKline Has Been Dismissed Pursuant To The Settlement Agreement

  12/22/2006

• Introgen Therapeutics, Inc. Obtains Exclusive Licenses To Family Of mda-7/IL-24 Technologies

  12/22/2006

• Oxford BioMedica PLC And Sigma-Aldrich Corporation Issue Joint Licence For LentiVector® Technology To GlaxoSmithKline

  12/21/2006

• GlaxoSmithKline To Acquire Praecis Pharmaceuticals Incorporated For $54.8M

  12/21/2006

• Neurocrine Biosciences, Inc. Announces Initiation Of Phase II Clinical Trials With CRF1 Antagonist For Anxiety And IBS

  12/20/2006

• GlaxoSmithKline Completes Acquisition Of CNS, Inc.

  12/19/2006

• The Day In Review: GlaxoSmithKline Pays Record For Genmab A/S Cancer Drug

  12/18/2006

• The Day In Review: BioSante Pharmaceuticals, Inc. Rises On FDA Approval

  12/18/2006

• The Day In Review: Deals Dominate Biotech News

  12/12/2006